Context Therapeutics Inc (NASDAQ: CNTX) soared 33.9% after announcing positive data from its window-of-opportunity clinical trial of onapristone extended-release (ONA-XR) in patients with early breast cancer who are past menopause. The clinical tr

Vyne Therapeutics Inc (NASDAQ: VYNE) stock is up 23% premarket on the back of seeming momentum from analyst coverage. H.C. Wainright initiated coverage of Vyne and indicated a target price of $7 for the stock. This has

The CEO of Everbridge Inc (NASDAQ: EVGB) resigned unexpectedly last night the company announced and the stock is down 27% premarket this morning. A good example of what markets really hate is uncertainty. The future of

Since January, the EQTEC PLC (LON: EQT) share price has fallen 51% despite the waste gasification company making significant progress in multiple projects across Europe. It appears investors are discounting the progress made by Eqtex this year fol

Distribution Finance Capital Holdings (LON: DFCH) share price rather wilted this week as the main shareholder announced the sale of its entire stake. The secondary placing in Distribution Finance has been completed and

Omega Diagnostics Group Plc (LON: ODX) share price plunged 31% after issuing an update on its contract with the Department of Health and Social Care (DHSC), which expired on 1 October 2021, after months of limbo. Investors reacted negatively to th

Tertiary Minerals PLC (LON: TYM) shares fell 10% this morning on the publication of the audited year-end results up to 30 Sept 2021. This marks a roughly 50% fall in the share price since the summer.

Ariana Resources PLC (LON: AAU) shares are up slightly on the news that Panther Metals Ltd has listed on the ASX. This is taken as the first step in proving the concept of the Asgard Metals Fund.

Deepverge PLC (LON: DVRG) share price spiked 12.3% after unveiling plans to launch the third generation of its compact Microtox PD COVID-19 detection system, which works in areas where large groups of people gather. The pandemic surveillance syste

Go-Ahead Group PLC (LON: GOG) isn’t going ahead with a 15% share price drop on suspension worries. The problem is that Go-Ahead has to restate its accounts for some years and it’s most unlikely that it will be able to

Open Orphan (LON: ORPH) shareholders have been given a boost Friday after the company's subsidiary, hVIVO, signed a $13.4 million contract with a US-based biotechnology firm. 

Lucid Group (NASDAQ: LCID) stock plunged just under 10% in early Thursday trading, following a contentious decision to offer $1.75B in senior convertible notes - a debt instrument often used to raise money from investo

Kyndryl Holdings (NYSE: KD) failed to move on Thursday’s market open, despite announcing promising agreements with both Google and defense contractor Raytheon Technologies. Buyers remain absent as the stock moves predo

Today marks two days of solid gains for EVgo (NASDAQ: EVGO), the US’s largest public EV fast-charging network. The critical factor here, and the reason why the company is causing such a stir with its imminent growth st

The Inspira Technologies Oxy BHN Ltd (NASDAQ: IINN) stock price soared 72.9% higher after revealing that it had signed a 7-year agreement with Innovimed for the potential deployment of 1,522 ART systems in the Czech Republic, Poland and Slovakia.

Ensysce Biosciences Inc (NASDAQ: ESNC) stock is looking increasingly like a momentum trade as it is up 85% premarket this morning following the over 100% price since Tuesday. T

CloudCall, the software and telecommunications company, has seen its shares rally 64% to 78p after agreeing to be taken over by Xplorer Capital Management for £39.9 million.

American Virtual Cloud Technologies Inc (NASDAQ: AVCT) soared 53.4% during premarket trading after announcing that it expects to grow its revenues to $18.8 million in 2021 from last year’s $14.3 million. The company also revealed that it expects i

Reata Pharmaceuticals Inc (NASDAQ: RETA) stock is down another 45% in premarket trading today. This follows on from the Food and Drug Administration’s refusal to grant approval to Reata’s kidney drug, bardoxolone methy

Code Chain New Continent Ltd (NASDAQ: CCNC) stock price plunged 37%, erasing all the gains made since announcing plans to expand its Bitcoin mining activities to North America. The company, based in China, is planning to expand its mining capacity